Fasil Tekola-Ayele
Overview
Explore the profile of Fasil Tekola-Ayele including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
98
Citations
1571
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Gleason J, Lambert C, Chen Z, Wagner K, Mendola P, Ouidir M, et al.
BMJ Public Health
. 2025 Feb;
2(2):e001014.
PMID: 40018530
Introduction: Racial and ethnic differences in fetal growth and birth size in the USA have not been adequately explained by individual-level socioeconomic status (SES) factors. We explored whether differences may...
2.
Habtewold T, Wijesiriwardhana P, Biedrzycki R, Zhang C, Grantz K, Grewal J, et al.
Clin Epigenetics
. 2025 Feb;
17(1):19.
PMID: 39915864
Background: Dysregulation of maternal glucose homeostasis has been related to an increased risk of morbidity and mortality in mothers and fetuses, yet the mechanism remains unclear. This study investigated the...
3.
Alemu R, Sharew N, Arsano Y, Ahmed M, Tekola-Ayele F, Mersha T, et al.
Hum Genomics
. 2025 Jan;
19(1):8.
PMID: 39891174
Non-communicable diseases (NCDs) such as cardiovascular diseases, chronic respiratory diseases, cancers, diabetes, and mental health disorders pose a significant global health challenge, accounting for the majority of fatalities and disability-adjusted...
4.
Wagner K, Gleason J, Chen Z, Zhang C, Hinkle S, He D, et al.
Diabetes Care
. 2024 Oct;
47(12):2180-2188.
PMID: 39413344
Objective: Gestational diabetes mellitus (GDM) increases the risk of fetal overgrowth as measured by two-dimensional ultrasonography. Whether fetal three-dimensional (3D) soft tissue and organ volumes provide additional insight into fetal...
5.
Habtewold T, Wijesiriwardhana P, Biedrzycki R, Tekola-Ayele F
Hum Genomics
. 2024 Jul;
18(1):81.
PMID: 39030631
Background: Maternal genetic risk of type 2 diabetes (T2D) has been associated with fetal growth, but the influence of genetic ancestry is not yet fully understood. We aimed to investigate...
6.
Herrera-Rivero M, Adli M, Akiyama K, Akula N, Amare A, Ardau R, et al.
Int J Bipolar Disord
. 2024 Jun;
12(1):20.
PMID: 38865039
Background: Lithium (Li) remains the treatment of choice for bipolar disorders (BP). Its mood-stabilizing effects help reduce the long-term burden of mania, depression and suicide risk in patients with BP....
7.
Grantz K, Lee W, Mack L, Sanz Cortes M, Goncalves L, Espinoza J, et al.
Am J Obstet Gynecol
. 2024 Jun;
232(3):324.e1-324.e160.
PMID: 38838912
Background: A major goal of contemporary obstetrical practice is to optimize fetal growth and development throughout pregnancy. To date, fetal growth during prenatal care is assessed by performing ultrasonographic measurement...
8.
Herrera-Rivero M, Adli M, Akiyama K, Akula N, Amare A, Ardau R, et al.
Res Sq
. 2023 Dec;
PMID: 38077040
Background: Lithium (Li) remains the treatment of choice for bipolar disorders (BP). Its mood-stabilizing effects help reduce the long-term burden of mania, depression and suicide risk in patients with BP....
9.
Saeed H, Wu J, Tesfaye M, Grantz K, Tekola-Ayele F
Am J Obstet Gynecol MFM
. 2023 Nov;
6(1):101237.
PMID: 38012987
Background: Antenatal maternal depression is associated with poor pregnancy outcomes and long-term effects on the offspring. Previous studies have identified links between antenatal depression and placental DNA methylation and between...
10.
Amare A, Thalamuthu A, Schubert K, Fullerton J, Ahmed M, Hartmann S, et al.
Mol Psychiatry
. 2023 Jul;
28(12):5251-5261.
PMID: 37433967
Lithium is regarded as the first-line treatment for bipolar disorder (BD), a severe and disabling mental health disorder that affects about 1% of the population worldwide. Nevertheless, lithium is not...